Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cellebrite Increases 2024 Revenue Outlook From $370M - $380M To $390M - $398M (Est $378.306M); Sees $100M - $104M For Q3 (Est $94.77M)

Author: Benzinga Newsdesk | August 15, 2024 07:26am

Posted In: CLBT